medigraphic.com

2015, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S1)

Frequency, clinical evolution and prognosis of toxic megacolon

Magallón-Tapia M, Ceniceros RA, Arenas-Osuna J, Juarez-Leal CL, Peralta-Amaro AL

Language: Spanish
References: 25
Page: 88-93
PDF size: 88.82 Kb.


ABSTRACT

Introduction: Toxic megacolon (MT) is a potentially lethal complication of infl ammatory, ischemic and infectious colitis. Usually it is related to ulcerative nonspecific colitis or Crohn disease. Recently it has been observed an increased in pseudomembranous colitis as cause of TM. The aim of this study is to describe the frequency, clinical evolution and prognosis of patients with TM.
Methods: Retrospective study, from January 2009 to January 2014 1500 patients were hospitalized in the Department of Coloproctology. We included 13 of 1500 patients with diagnosis of TM according to Jalan criteria and surgically corroborated. To determine the averages descriptive statistics was used.
Results: We studied 13 patients with TM (79.9 % male and 20.1 % female), the average age was 47.69 ± 18.3 years. The most frequently associated diseases were: nonspecifi c ulcerative colitis (30.8 %), pseudomembranous colitis (30.8 %), neutropenic colitis (23.1 %), Crohn Disease (7.7 %) and ischemic colitis (7.7 %). Subtotal colectomy plus terminal ileostomy was done in 84.6 %, extended right hemicolectomy with ileostomy plus mucous fistula in 7.7 % and extended right hemicolectomy with ileostomy plus Hartmann pouch in 7.7 %. The mortality was 61.5 %. The prevalence in the 5 years was 13 of 1500 (0.86 %) patients.
Conclusions: The prevalence of TM is low with a high mortality. A prompt diagnosis and treatment can improve the poor prognosis in these patients.


REFERENCES

  1. Carrillo-Esper R, Calderón-Álvarez JL, Muciño-Bermejo J, Ramírez-Rosillo FJ. Megacolon tóxico. Med Int Mex. 2012;28(3):282-7.

  2. González V, Pére JL, Marín I. Actitud ante un megacolon tóxico. Rev Esp Enferm Dig. 2003;95(6):415-21.

  3. Graziano A, Ramírez Rojas P. Megacolon tóxico. Cirugía Digestiva, F. Galindo. 2009; III-354: pág. 1-13.

  4. Thirunavuk B, Shanthi A, Jayakumar P, Poonam K. Unusual Complication of Toxic Megacolon in Typhoid Colitis. ndian J Pediatr. May 2014,81(5):504-6.

  5. Bains S, Lloyd G.M, Sutton CD, West K, Miller AS. A case of toxic megacolon in a patient with collagenous colitis. Tech Coloproctol (2009) 13:165-6.

  6. Arun-Babu T, Ananthakrishnan S, Jayakumar P, Kullu P. Unusual complication of toxic megacolon in typhoid colitis. Indian J Pediatr. 2014 May;81(5):504-6.

  7. Brodrick R, Sagar J. Toxic megacolon from sexually transmitted Shigella sonnei infection. Int J Colorectal Dis. 2012 Mar;27(3):415.

  8. Wade JW. Toxic megacolon after abdominoplasty: a case report. Ann Plast Surg. 2014 Jun; 72(6):S170-1.

  9. Inoue K, Wakabayashi N, Fukumoto K, Yamada S, Bito N, Yoshida N, et al. Toxic megacolon associated with cytomegalovirus infection in a patient with steroid-naïve ulcerative colitis. Intern Med. 2012;51 (19):2739-43.

  10. Wolff BG, Boller AM. Toxic megacolon. 2009 Springer Science Business Media, LLC. Pag 827-32.

  11. Grieco MB, Bordan DL, Geiss AC, Beil AR. Toxic megacolon complicating Crohn’s colitis. Ann Surg 1991:75-80.

  12. Hokama A, Ohira T, Kishimoto K, Kinjo F, Fujita J. Impending megacolon: small bowel distension as a predictor of toxic megacolon in ulcerative colitis. Intern Emerg Med (2012) 7:487-8.

  13. Hefaiedh R, Cheikh M, Ennaifer R, Gharbi L, Bel N. Toxic megacolon complicating a fi rst course of Crohn’s disease: about two cases. Clinics and Practice 2013; volume 3:63-4.

  14. García A, Abenamar J, Blas R, et al. Megacolon tóxico por colitis pseudomembranosa. ActA MédicA Grupo ÁnGeles., octubre-diciembre 2011;Volumen 9(4):217-20.

  15. Leena S, Darshan K, Robert J R. Toxic megacolon associated Clostridium diffi cile colitis. World J Gastrointest Endosc August 2010 16;2(8):293-7.

  16. Strauss RJ, Flint GW, Platt N. The surgical management of toxic dilatation of the colon: A report of 28 cases and review of the literature. Ann Surg 1976; 184:682-8.

  17. Jalan KN, Sircus W, Card WI, et al. (1969) An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroen- terology 57:68-82.

  18. Greenstein AJ, Sachar DB, Gibas A, Heimann T, Janowitz HD, Aufses AH. Outcome of toxic dilatation in ulcerative and Crohn’s colitis. J Clin Gastroenterol 1985;7:137-43.

  19. Wilbert P, Takeshi M. Colitis fulminante y megacolon toxico. Colon Recto y Ano. Editor DR Takeshi M. Vol 1: pag 260-4.

  20. Miniello S, Marzaioli R, Balzanelli MG, Dantona C, Lippolis AS, et al. Toxic megacolon in ulcerative rectocolitis. Current trends in clinical evaluation, diagnosis and treatment. Ann Ital Chir. 2014;85:45-9.

  21. Yu S, Abdelkarim A, Nawras A, Hinch BT, Mbaso C, Valavoor S, et al. Fecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Diffi cile Colitis in a Patient With Duchenne Muscular Dystrophy. Am J Ther. 2014 May 22.

  22. Antonopoulos P, Almyroudi M, Kolonia V, Kouris S, Troumpoukis N, Economou N. Toxic Megacolon and Acute Ischemia of the Colon due to Sigmoid Stenosis Related to Diverticulitis. Case Rep Gastroenterol. 2013 Sep 11;7(3):409-13.

  23. van-Geenen EJ, Sachar DB. Infl iximab in Crohn’s disease-associated toxic megacolon. J Clin Gastroenterol. 2012 Apr;46(4):321-3.

  24. Frasko R, Uchytil Z, Sváb J, Výborný J, Krska Z. Treatment outcomes in patients with toxic megacolon, Rozhl Chir. 2011 Jun;90(6):339-42.

  25. Autenrieth DM, Baumgart DC. Toxic megacolon. Infl amm Bowel Dis. 2012 Mar;18(3):584-91.




2020     |     www.medigraphic.com